Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme
Abstract Background Adverse effects of antileishmanial drugs can affect patients’ quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). In Bangladesh, there are 26 treatment centers that manage leishmaniasis cases coming from 100 end...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2018-08-01
|
| Serier: | Infectious Diseases of Poverty |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s40249-018-0461-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
